THE JOHNS HOPKINS MEDICAL INSTITUTIONS
Gallbladder and Bile Duct Cancer Web
Discussion Boardquestion was posted 11/26/2001 06:43 pm by peter argani
E-mail Address: firstname.lastname@example.org
CA19-9 is used to follow patients with both biliary and pancreatic cancers.
It is not an absolutely specific marker, since it can be elevated in patients
hope this helps,
Reply to this message |
Return to Main Message List
No replies on file.
DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions.Patients are advised to consult their personal physicians before making any medical decisions.
Biliary Ca Home | Feedback | Pathology Home | Oncology Center Home Copyright © 2020 The Johns Hopkins University, Baltimore, MarylandLast Modified: 11/11/2002 10:50 am